Stifel Nicolaus Reiterates “Buy” Rating for Perrigo Company PLC (PRGO)
Perrigo Company PLC (NASDAQ:PRGO)‘s stock had its “buy” rating reiterated by investment analysts at Stifel Nicolaus in a note issued to investors on Thursday, Analyst Ratings.Net reports. They currently have a $160.00 target price on the stock, down from their previous target price of $175.00. Stifel Nicolaus’ target price points to a potential upside of 22.56% from the stock’s previous close.
A number of other firms have also recently commented on PRGO. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Thursday. They now have a $137.00 price target on the stock. Separately, analysts at B. Riley cut their price target on shares of Perrigo Company PLC from $170.00 to $157.00 in a research note on Thursday. They now have a “neutral” rating on the stock. Finally, analysts at Buckingham Research downgraded shares of Perrigo Company PLC from a “buy” rating to a “neutral” rating in a research note on Thursday. They now have a $140.00 price target on the stock, down previously from $187.00. One analyst has rated the stock with a sell rating, three have given a hold rating and ten have assigned a buy rating to the company. Perrigo Company PLC presently has an average rating of “Buy” and a consensus price target of $159.91.
Shares of Perrigo Company PLC (NASDAQ:PRGO) traded down 3.77% on Thursday, hitting $125.63. The stock had a trading volume of 2,633,954 shares. Perrigo Company PLC has a 52-week low of $112.05 and a 52-week high of $168.39. The stock’s 50-day moving average is $149.2 and its 200-day moving average is $152.1. The company has a market cap of $16.803 billion and a price-to-earnings ratio of 48.82.
Perrigo Company PLC (NASDAQ:PRGO) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.51 by $0.20. The company had revenue of $1,000.00 million for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter in the previous year, the company posted $1.42 earnings per share. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. Analysts expect that Perrigo Company PLC will post $6.54 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, June 17th. Investors of record on Friday, May 30th will be paid a dividend of $0.105 per share. This represents a $0.42 annualized dividend and a dividend yield of 0.32%. The ex-dividend date is Wednesday, May 28th.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.